- $34.26m
- $41.85m
- $0.33m
Annual income statement for Pluri, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.023 | 0 | 0.234 | 0.287 | 0.326 |
| Cost of Revenue | |||||
| Gross Profit | 0.023 | 0 | — | 0.278 | 0.322 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 29.5 | 50.6 | 41.8 | 27.5 | 22.5 |
| Operating Profit | -29.5 | -50.6 | -41.6 | -27.2 | -22.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -29.2 | -49.9 | -41.4 | -28.9 | -21.3 |
| Net Income After Taxes | -29.2 | -49.9 | -41.4 | -28.9 | -21.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -29.2 | -49.9 | -41.4 | -28.3 | -20.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -29.2 | -49.9 | -41.4 | -28.3 | -20.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -12.6 | -14 | -10.1 | -6.02 | -3.87 |